 |
PDBsum entry 2jcs
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.1.145
- deoxynucleoside kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 2'-deoxyribonucleoside + ATP = a 2'-deoxyribonucleoside 5'-phosphate + ADP + H+
|
 |
 |
 |
 |
 |
2'-deoxyribonucleoside
|
+
|
ATP
Bound ligand (Het Group name = )
matches with 76.47% similarity
|
=
|
2'-deoxyribonucleoside 5'-phosphate
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Febs J
274:1542-1551
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Functional studies of active-site mutants from Drosophila melanogaster deoxyribonucleoside kinase. Investigations of the putative catalytic glutamate-arginine pair and of residues responsible for substrate specificity.
|
|
L.Egeblad-Welin,
Y.Sonntag,
H.Eklund,
B.Munch-Petersen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The catalytic reaction mechanism and binding of substrates was investigated for
the multisubstrate Drosophila melanogaster deoxyribonucleoside kinase. Mutation
of E52 to D, Q and H plus mutations of R105 to K and H were performed to
investigate the proposed catalytic reaction mechanism, in which E52 acts as an
initiating base and R105 is thought to stabilize the transition state of the
reaction. Mutant enzymes (E52D, E52H and R105H) showed a markedly decreased
k(cat), while the catalytic activity of E52Q and R105K was abolished. The E52D
mutant was crystallized with its feedback inhibitor dTTP. The backbone
conformation remained unchanged, and coordination between D52 and the dTTP-Mg
complex was observed. The observed decrease in k(cat) for E52D was most likely
due to an increased distance between the catalytic carboxyl group and 5'-OH of
deoxythymidine (dThd) or deoxycytidine (dCyd). Mutation of Q81 to N and Y70 to W
was carried out to investigate substrate binding. The mutations primarily
affected the K(m) values, whereas the k(cat) values were of the same magnitude
as for the wild-type. The Y70W mutation made the enzyme lose activity towards
purines and negative cooperativity towards dThd and dCyd was observed. The Q81N
mutation showed a 200- and 100-fold increase in K(m), whereas k(cat) was
decreased five- and twofold for dThd and dCyd, respectively, supporting a role
in substrate binding. These observations give insight into the mechanisms of
substrate binding and catalysis, which is important for developing novel suicide
genes and drugs for use in gene therapy.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Hébrard,
C.Dumontet,
and
L.P.Jordheim
(2009).
Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues.
|
| |
Cancer Gene Ther,
16,
541-550.
|
 |
|
|
|
|
 |
M.J.Pérez-Pérez,
E.M.Priego,
A.I.Hernández,
O.Familiar,
M.J.Camarasa,
A.Negri,
F.Gago,
and
J.Balzarini
(2008).
Structure, physiological role, and specific inhibitors of human thymidine kinase 2 (TK2): present and future.
|
| |
Med Res Rev,
28,
797-820.
|
 |
|
|
|
|
 |
N.E.Mikkelsen,
B.Munch-Petersen,
and
H.Eklund
(2008).
Structural studies of nucleoside analog and feedback inhibitor binding to Drosophila melanogaster multisubstrate deoxyribonucleoside kinase.
|
| |
FEBS J,
275,
2151-2160.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |